Literature DB >> 31036733

Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis.

Sofia Bota1, Pedro Alves2, Claudia Constantino3, Raquel Maia1,4.   

Abstract

Hypereosinophilic syndromes are rare in children. Sporadic, mild-severity FIP1L1-platelet-derived growth factor receptor α (PDGFRα) rearrangement cases have been reported, mainly in boys. We present the case of a 5-year-old girl referred from her African country of birth, due to severe constitutional symptoms, multifocal bone pain, headache, gastrointestinal complaints, cardiomyopathy and unexplained hypereosinophilia. She presented multiple end-organ diseases and striking bone involvement. Although she had a positive serology for Strongyloides stercoralis, extensive evaluation detected a FIP1L1-PDGFRA fusion gene. Systemic corticosteroids and low-dose imatinib were started and the child became asymptomatic. After 9 months of treatment, FIP1L1-PDGFRA was no longer detected. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  paediatric oncology; radiology; tropical medicine (infectious disease)

Mesh:

Substances:

Year:  2019        PMID: 31036733      PMCID: PMC6506024          DOI: 10.1136/bcr-2018-227653

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Hypereosinophilic syndrome in children.

Authors:  M van Grotel; M de Hoog; R R de Krijger; H B Beverloo; M M van den Heuvel-Eibrink
Journal:  Leuk Res       Date:  2012-06-22       Impact factor: 3.156

2.  Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement.

Authors:  Susana Rives; Iñaki Alcorta; Teresa Toll; Esperanza Tuset; Jesús Estella; Nicholas C P Cross
Journal:  J Pediatr Hematol Oncol       Date:  2005-12       Impact factor: 1.289

3.  Hypereosinophilia in Children and Adults: A Retrospective Comparison.

Authors:  Kelli W Williams; JeanAnne Ware; Annalise Abiodun; Nicole C Holland-Thomas; Paneez Khoury; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2016-04-27

4.  Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.

Authors:  Mathias Rathe; Thomas Kielsgaard Kristensen; Michael Boe Møller; Niels L T Carlsen
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

5.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

6.  Molecular characterization of paediatric idiopathic hypereosinophilia.

Authors:  Maria Cristina Rapanotti; Roberta Caruso; Emanuele Ammatuna; Serena Zaza; Laura Trotta; Mariadomenica Divona; Laura Cicconi; Daria Funaro; Giorgio Federici; Sergio Amadori; Giulio De Rossi; Francesco Lo-Coco
Journal:  Br J Haematol       Date:  2010-10-19       Impact factor: 6.998

Review 7.  FIP1L1-PDGFRα-positive hypereosinophilic syndrome in childhood: a case report and review of literature.

Authors:  Piero Farruggia; Emilia Giugliano; Delia Russo; Angela Trizzino; Roberta Lorenzatti; Alessandra Santoro; Paolo D'Angelo
Journal:  J Pediatr Hematol Oncol       Date:  2014-01       Impact factor: 1.289

Review 8.  Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.

Authors:  J Gotlib; J Cools
Journal:  Leukemia       Date:  2008-10-09       Impact factor: 11.528

Review 9.  The laboratory diagnosis and follow up of strongyloidiasis: a systematic review.

Authors:  Ana Requena-Méndez; Peter Chiodini; Zeno Bisoffi; Dora Buonfrate; Eduardo Gotuzzo; José Muñoz
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

10.  The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases.

Authors:  Fanny Legrand; Aline Renneville; Elizabeth MacIntyre; Samuel Mastrilli; Felix Ackermann; Jean Michel Cayuela; Philippe Rousselot; Aline Schmidt-Tanguy; Olivier Fain; Marc Michel; Jean-Pierre de Jaureguiberry; Pierre-Yves Hatron; Pascale Cony-Makhoul; Didier Lefranc; Damien Sène; Vincent Cottin; Mohamed Hamidou; Olivier Lidove; André Baruchel; Sylvain Dubucquoi; Olivier Bletry; Claude Preudhomme; Monique Capron; Lionel Prin; Jean Emmanuel Kahn
Journal:  Medicine (Baltimore)       Date:  2013-09       Impact factor: 1.889

View more
  1 in total

1.  Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia.

Authors:  Juhi Jain; Elizabeth P Weinzierl; Debra Saxe; John Bergsagel; Jason Gotlib; Andreas Reiter; Sunil S Raikar
Journal:  Hemasphere       Date:  2020-11-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.